A detailed history of Met Life Investment Management, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 92,342 shares of AMRX stock, worth $782,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,342
Previous 92,342 -0.0%
Holding current value
$782,136
Previous $586,000 31.06%
% of portfolio
0.0%
Previous 0.0%

Shares

56 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.36 - $7.11 $190,998 - $253,357
35,634 Added 62.84%
92,342 $586,000
Q1 2024

May 14, 2024

BUY
$5.24 - $6.34 $297,149 - $359,528
56,708 New
56,708 $343,000
Q3 2023

May 09, 2024

BUY
$2.76 - $4.59 $113,154 - $188,180
40,998 Added 147.41%
68,810 $290,000
Q2 2023

Apr 29, 2024

BUY
$1.33 - $3.1 $91,517 - $213,311
68,810 New
68,810 $213,000
Q2 2023

Aug 10, 2023

BUY
$1.33 - $3.1 $54,527 - $127,093
40,998 Added 147.41%
68,810 $213,000
Q1 2023

May 09, 2024

BUY
$1.27 - $2.7 $35,321 - $75,092
27,812 New
27,812 $38.7 Million
Q1 2023

May 15, 2023

SELL
$1.27 - $2.7 $23,792 - $50,581
-18,734 Reduced 40.25%
27,812 $38,000
Q4 2022

May 10, 2024

SELL
$1.96 - $2.61 $18,584 - $24,748
-9,482 Reduced 16.92%
46,546 $92,000
Q4 2022

Jun 14, 2023

BUY
$1.96 - $2.61 $36,718 - $48,895
18,734 Added 67.36%
46,546 $92,000
Q4 2022

Mar 22, 2023

SELL
$1.96 - $2.61 $18,584 - $24,748
-9,482 Reduced 16.92%
46,546 $92,000
Q4 2022

Feb 15, 2023

SELL
$1.96 - $2.61 $18,584 - $24,748
-9,482 Reduced 16.92%
46,546 $92,000
Q3 2022

May 10, 2024

BUY
$2.02 - $3.62 $54,016 - $96,802
26,741 Added 91.31%
56,028 $113,000
Q3 2022

Jun 14, 2023

BUY
$2.02 - $3.62 $56,996 - $102,141
28,216 Added 101.45%
56,028 $113,000
Q3 2022

Mar 22, 2023

BUY
$2.02 - $3.62 $54,016 - $96,802
26,741 Added 91.31%
56,028 $113,000
Q3 2022

Nov 14, 2022

BUY
$2.02 - $3.62 $54,016 - $96,802
26,741 Added 91.31%
56,028 $113,000
Q2 2022

May 10, 2024

SELL
$3.01 - $4.46 $87,368 - $129,455
-29,026 Reduced 49.78%
29,287 $93,000
Q2 2022

Jun 20, 2023

BUY
$3.01 - $4.46 $4,439 - $6,578
1,475 Added 5.3%
29,287 $93,000
Q2 2022

Mar 22, 2023

SELL
$3.01 - $4.46 $87,368 - $129,455
-29,026 Reduced 49.78%
29,287 $93,000
Q2 2022

Aug 11, 2022

SELL
$3.01 - $4.46 $87,368 - $129,455
-29,026 Reduced 49.78%
29,287 $93,000
Q1 2022

May 10, 2024

BUY
$3.9 - $4.89 $227,420 - $285,150
58,313 New
58,313 $243,000
Q1 2022

Jun 20, 2023

BUY
$3.9 - $4.89 $118,953 - $149,149
30,501 Added 109.67%
58,313 $243,000
Q1 2022

Mar 22, 2023

BUY
$3.9 - $4.89 $143,005 - $179,306
36,668 Added 169.41%
58,313 $243,000
Q1 2022

May 12, 2022

BUY
$3.9 - $4.89 $143,005 - $179,306
36,668 Added 169.41%
58,313 $243,000
Q4 2021

May 17, 2024

SELL
$3.95 - $5.85 $74,102 - $109,746
-18,760 Reduced 46.43%
21,645 $103,000
Q4 2021

Jun 21, 2023

SELL
$3.95 - $5.85 $24,359 - $36,076
-6,167 Reduced 22.17%
21,645 $103,000
Q4 2021

Mar 22, 2023

SELL
$3.95 - $5.85 $74,102 - $109,746
-18,760 Reduced 46.43%
21,645 $103,000
Q4 2021

Feb 15, 2022

SELL
$3.95 - $5.85 $74,102 - $109,746
-18,760 Reduced 46.43%
21,645 $104,000
Q3 2021

Jun 21, 2023

BUY
$4.31 - $5.64 $54,275 - $71,024
12,593 Added 45.28%
40,405 $215,000
Q2 2021

Jun 21, 2023

BUY
$5.12 - $6.82 $64,476 - $85,884
12,593 Added 45.28%
40,405 $206,000
Q1 2021

May 17, 2024

SELL
$4.74 - $7.38 $77,276 - $120,316
-16,303 Reduced 28.75%
40,405 $271,000
Q1 2021

Jun 26, 2023

BUY
$4.74 - $7.38 $59,690 - $92,936
12,593 Added 45.28%
40,405 $272 Million
Q1 2021

Mar 22, 2023

BUY
$4.74 - $7.38 $91,899 - $143,083
19,388 Added 92.25%
40,405 $271,000
Q1 2021

May 14, 2021

BUY
$4.74 - $7.38 $91,899 - $143,083
19,388 Added 92.25%
40,405 $272,000
Q4 2020

May 24, 2024

SELL
$3.95 - $5.42 $53,960 - $74,042
-13,661 Reduced 39.39%
21,017 $96,000
Q4 2020

Jun 22, 2023

SELL
$3.95 - $5.42 $26,840 - $36,828
-6,795 Reduced 24.43%
21,017 $96,000
Q4 2020

Mar 22, 2023

SELL
$3.95 - $5.42 $53,960 - $74,042
-13,661 Reduced 39.39%
21,017 $96,000
Q4 2020

Feb 16, 2021

SELL
$3.95 - $5.42 $53,960 - $74,042
-13,661 Reduced 39.39%
21,017 $96,000
Q3 2020

May 24, 2024

SELL
$3.54 - $5.27 $72,906 - $108,535
-20,595 Reduced 37.26%
34,678 $135 Million
Q3 2020

Jun 26, 2023

BUY
$3.54 - $5.27 $24,305 - $36,183
6,866 Added 24.69%
34,678 $134,000
Q3 2020

Mar 22, 2023

SELL
$3.54 - $5.27 $72,906 - $108,535
-20,595 Reduced 37.26%
34,678 $134,000
Q3 2020

Nov 13, 2020

SELL
$3.54 - $5.27 $72,906 - $108,535
-20,595 Reduced 37.26%
34,678 $135,000
Q2 2020

May 24, 2024

SELL
$2.87 - $5.46 $4,118 - $7,835
-1,435 Reduced 2.53%
55,273 $263 Million
Q2 2020

Jun 26, 2023

BUY
$2.87 - $5.46 $78,813 - $149,937
27,461 Added 98.74%
55,273 $263,000
Q1 2020

Jul 12, 2023

BUY
$2.46 - $5.35 $67,554 - $146,916
27,461 Added 98.74%
55,273 $192,000
Q4 2019

Jul 12, 2023

BUY
$2.65 - $5.56 $72,771 - $152,683
27,461 Added 98.74%
55,273 $266,000
Q4 2019

Mar 22, 2023

BUY
$2.65 - $5.56 $39,050 - $81,932
14,736 Added 36.35%
55,273 $266,000
Q4 2019

Feb 14, 2020

BUY
$2.65 - $5.56 $39,050 - $81,932
14,736 Added 36.35%
55,273 $266,000
Q3 2019

Jul 12, 2023

BUY
$2.29 - $7.1 $29,140 - $90,347
12,725 Added 45.75%
40,537 $117,000
Q2 2019

Jul 12, 2023

BUY
$6.44 - $14.29 $81,949 - $181,840
12,725 Added 45.75%
40,537 $290,000
Q1 2019

Jul 13, 2023

BUY
$11.87 - $14.84 $151,045 - $188,839
12,725 Added 45.75%
40,537 $574,000
Q4 2018

Jul 13, 2023

BUY
$13.09 - $21.49 $166,570 - $273,460
12,725 Added 45.75%
40,537 $548,000
Q4 2018

Mar 22, 2023

SELL
$13.09 - $21.49 $292,666 - $480,473
-22,358 Reduced 35.55%
40,537 $548,000
Q4 2018

Feb 14, 2019

SELL
$13.09 - $21.49 $292,666 - $480,473
-22,358 Reduced 35.55%
40,537 $548,000
Q3 2018

Jul 13, 2023

BUY
$16.4 - $24.27 $208,689 - $308,835
12,725 Added 45.75%
40,537 $899,000
Q3 2018

Mar 22, 2023

BUY
$16.4 - $24.27 $268,123 - $396,790
16,349 Added 35.12%
62,895 $1.4 Million
Q3 2018

Nov 14, 2018

BUY
$16.4 - $24.27 $1.03 Million - $1.53 Million
62,895 New
62,895 $1.4 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.28B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.